These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9290755)

  • 1. Cholesterol reduction in cyclosporine-treated renal transplant patients: effect on platelet-derived growth factor levels and platelet activation.
    Rigatto O; Rush D; Perry Y; Walker S; Bose R; Bolli P
    Transplant Proc; 1997 Sep; 29(6):2591-2. PubMed ID: 9290755
    [No Abstract]   [Full Text] [Related]  

  • 2. Arterial hypertension in renal transplantation.
    Sandrini S; Gaggia P; Bracchi M; Gaggiotti M; Brunori G; Maiorca R
    Contrib Nephrol; 1996; 119():16-25. PubMed ID: 8783585
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic approach with patient-specific cyclosporine administration protocol in renal transplantation.
    Sernyak PS; Chernobrivtsev PA; Kalinin DI; Lunyova AG; Denisov VK
    Transplant Proc; 1997; 29(1-2):296. PubMed ID: 9123003
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive therapy regimen and platelet activation in renal transplant patients.
    Graff J; Klinkhardt U; Harder S; Wegert W; Lenz T; Scheuermann EH; Gossmann J
    Clin Pharmacol Ther; 2002 Oct; 72(4):411-8. PubMed ID: 12386643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus.
    Friemann S; Feuring E; Padberg W; Ernst W
    Transplant Proc; 1998 Jun; 30(4):1240-2. PubMed ID: 9636504
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients.
    Colak T; Karakayali H; Yagmurdur MC; Moray G
    Transplant Proc; 2002 Sep; 34(6):2081-2. PubMed ID: 12270321
    [No Abstract]   [Full Text] [Related]  

  • 7. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of platelet-derived growth factor and its receptors in acute renal allograft rejection.
    Savikko J; Kallio EA; von Willebrand E
    Transplant Proc; 2001; 33(1-2):377-8. PubMed ID: 11266869
    [No Abstract]   [Full Text] [Related]  

  • 9. Involvement of platelet-derived growth factor and histocompatibility of DRB 1 in chronic renal allograft nephropathy.
    Yamada K; Hatakeyama E; Sakamaki T; Nishimura M; Arita S; Sakamoto K; Hamaguchi K; Nakajima K; Otsuka M; Tanabe K
    Transplantation; 2001 Apr; 71(7):936-41. PubMed ID: 11349729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients.
    Blume C; Hollenbeck M; Ivens K; Heering P; Hetzel GR; Grabensee B
    Transplant Proc; 2001; 33(7-8):3161-3. PubMed ID: 11750357
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation between serotonin concentration and blood pressure in kidney transplant recipients treated with cyclosporine.
    Azzadin A; Malyszko J; Malyszko JS; Buczko W; Mysliwiec M
    Nephron; 1996; 72(2):336-7. PubMed ID: 8684559
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients.
    Puig JM; Lloveras J; Fernández-Crespo P; Mir M; Iñigo V; Manresa JM; Masramón J
    Transplant Proc; 1999 Sep; 31(6):2259-60. PubMed ID: 10500567
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe vital depression as the presenting feature of cyclosporin-A-associated thrombotic microangiopathy.
    van der Molen LR; van Son WJ; Tegzess AM; Stegeman CA
    Nephrol Dial Transplant; 1999 Apr; 14(4):998-1000. PubMed ID: 10328490
    [No Abstract]   [Full Text] [Related]  

  • 14. Relation of magnesium level to cyclosporine and metabolic complications in renal transplant recipients.
    Ahmadi F; Naseri R; Lessan-Pezeshki M
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):766-9. PubMed ID: 19736470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine versus tacrolimus maintenance therapy in renal transplant.
    Alghamdi S; Nabi Z; Skolnik E; Alkorbi L; Albaqumi M
    Exp Clin Transplant; 2011 Jun; 9(3):170-4. PubMed ID: 21649564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 17. Neoral vs Sandimmun: interim results of a randomized trial of efficacy and safety in preventing acute rejection in new renal transplant recipients. The U. K. Neoral Study Group.
    Lodge JP; Pollard SG
    Transplant Proc; 1997; 29(1-2):272-3. PubMed ID: 9122991
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of early onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Kim W; La BJ; Lee S; Yu HC; Cho BH; Kang MJ; Park SK
    Clin Nephrol; 2003 Feb; 59(2):148-50. PubMed ID: 12608560
    [No Abstract]   [Full Text] [Related]  

  • 19. Gingival overgrowth in dogs associated with clinically relevant cyclosporine blood levels: observations in a canine renal transplantation model.
    Nam HS; McAnulty JF; Kwak HH; Yoon BI; Hyun C; Kim WH; Woo HM
    Vet Surg; 2008 Apr; 37(3):247-53. PubMed ID: 18394071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifocal alopecia areata during systemic cyclosporine A therapy.
    Cerottini JP; Panizzon RG; de Viragh PA
    Dermatology; 1999; 198(4):415-7. PubMed ID: 10490301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.